Evidence map›Paper›PMID 37204549›Full record

ArticleNeurochemical research2023

Effect of Rosiglitazone, the Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, on Apoptosis, Inflammatory Cytokines and Oxidative Stress in pentylenetetrazole-Induced Seizures in Kindled Mice.

Jinliang Li, Suping Chen, Feilong Wang, Jingyu Zhang, Mohammad Ali Zeyghami, Faramarz Koohsar, Ali Asghar Ayatollahi, Abolfazl Amini

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Jinliang LiDepartment of Pediatrics, Central People's Hospital of Zhanjiang, Zhanjiang, 524045, Guangdong, China.
Suping ChenDepartment of Pediatrics, Central People's Hospital of Zhanjiang, Zhanjiang, 524045, Guangdong, China.
Feilong WangDepartment of Pediatrics, Central People's Hospital of Zhanjiang, Zhanjiang, 524045, Guangdong, China.
Jingyu ZhangZhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Zhanjiang, 524045, Guangdong, China. yfyxxzjy@163.com.
Mohammad Ali ZeyghamiNeuroscience Research Center, Department of Pharmacology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Faramarz KoohsarLaboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Ali Asghar AyatollahiLaboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Abolfazl AminiDepartment of Medical Biotechnology, Faculty of Advanced Technologies in Medicine, Golestan University of Medical Sciences, Gorgan, Iran. amini_ab@msn.com.
Central People's Hospital of Zhanjiang · CNGolestan University · IR

Funding

Golestan University of Medical Sciences 940430115
6 · The paper itself

Abstract

A growing body of evidence has shown that seizure can trigger inflammatory cascades through increasing the expression of several inflammatory cytokines. It has been proved that peroxisome proliferator-activated receptor-γ agonists have immunomodulatory, anti-inflammatory, and neuroprotective effects beyond the putative hypoglycemic effects. Thus, we investigated the inhibitory effect of rosiglitazone on the development of pentylenetetrazol (PTZ)-induced kindling via affecting the inflammatory pathway. Male C57BL/6 mice were randomly divided into vehicle group (0.1% DMSO), PTZ-group and rosiglitazone-PTZ-group. Kindling was induced by the administration of PTZ (40 mg/kg, i.p) every other day and mice were observed for 20 min after each PTZ injection. Twenty-four hours after the last dose, animals were euthanized and hippocampus was isolated. The level of Malondialdehyde (MDA), Superoxide Dismutase (SOD), and Catalase (CAT) activity were quantified in hippocampus by biochemical methods. The protein levels of IL-1β, IL-6, IL-10, IFN-γ, TNF-α, caspase-3, iNOS, PPAR-γ, Bcl-2, or Bax factors were measured with western blotting. Also, the quantitative real-time PCR were used to evaluate the mRNA expression of those factors. Pretreatment with rosiglitazone significantly prevented the progression of kindling in comparison with control group. The rosiglitazone significantly decreased the MDA level and increased the CAT, and SOD levels in the rosiglitazone treated mice compared to those in the PTZ group (P < 0.01). Using real-time PCR and Western blotting assay, similar results were obtained. The expression levels of IL-1β, IL-6, IL-10, IFN-γ, TNF-α, Bax or PPAR-γ were significantly changed in the brain. The results of this study suggest that effect of rosiglitazone may be crucial in its ability to protect against the neuronal damage caused by PTZ induced seizure.

Indexed as

Kindling, NeurologicPentylenetetrazoleAnimalsAntioxidantsbcl-2-Associated X ProteinCytokinesInterleukin-10Interleukin-6MaleMiceMice, Inbred C57BLOxidative StressPPAR gammaPPAR-gamma AgonistsPyroptosisRosiglitazoneAntioxidantsbcl-2-Associated X ProteinCytokinesInterleukin-10Interleukin-6PentylenetetrazolePPAR gammaPPAR-gamma AgonistsRosiglitazoneSuperoxide DismutaseTumor Necrosis Factor-alphaApoptosisCytokineInflammationRosiglitazoneSeizure

Identifiers

PMID37204549
OpenAlexW4377093560

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.